Merck CEO Celebrates the Success of Cancer Drug as Sales Shoot up 20%

"The momentum is there," declared Merck President and CEO Robert Davis, as Keytruda sales soared 20%.

"We continue to see strong growth in non-small cell lung cancer as we look across the globe. But what this really reflects is the fact that we've been able to expand Keytruda into ever-increasing numbers of different tumor types that is driving the growth as we go into new indications."

H/T: https://rumble.com/v1q5mg7-cancer-drug-keytruda-sees-20-q3-sales-increase-for-merck.html

Support my work with a Substack subscription: https://vigilantfox.substack.com

Read my articles: https://redvoicemedia.com/vigilantfox

Follow my other socials: http://vigilantfox.id

Save big on MyPillow products at https://mypillow.com/vfox

“The best coffee you’ll ever try”: https://mystore.com/vfox

Save 5% off Z-Stack with coupon code FOX: https://zstacklife.com/?ref=wmpgvtrNa6bk

Protect your wealth from Bidenflation: https://www.gcjdjhs3e.com/3N116J/PS824/?uid=19